Vancomycin AUC/MIC Ratio and 30-Day Mortality in Patients With Staphylococcus Aureus Bacteremia

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01485-12
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Vancomycin Bactericidal Activity as a Predictor of 30-Day Mortality in Patients With Methicillin-Resistant Staphylococcus Aureus Bacteremia

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2011English

Risk Factors of Treatment Failure and 30-Day Mortality in Patients With Bacteremia Due to MRSA With Reduced Vancomycin Susceptibility

Scientific Reports
Multidisciplinary
2018English

Staphylococcus Aureus Bacteremia in Patients With Hematologic Disorders

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases
Medicine
1992English

Predictors of Relapse of Methicillin-Resistant Staphylococcus Aureus Bacteremia After Treatment With Vancomycin

Journal of Clinical Microbiology
Microbiology
2011English

Protection Against Staphylococcus Aureus Bacteremia-Induced Mortality Depends on ILC2s and Eosinophils

JCI insight
Medicine
2019English

Staphylococcus Aureus Bacteremia Associated With Pacemakers and Implantable Defibrillators

Infection Control and Hospital Epidemiology
EpidemiologyInfectious DiseasesMicrobiology
2001English

18 F-FDG-Pet/Ct Optimizes Treatment in Staphylococcus Aureus Bacteremia and Is Associated With Reduced Mortality

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2017English

Association of Vancomycin MIC and Molecular Characteristics With Clinical Outcomes in Methicillin-Susceptible Staphylococcus Aureus Acute Hematogenous Osteoarticular Infections in Children

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

Treatment and Outcome of Staphylococcus Aureus Bacteremia

Archives of Internal Medicine
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy